03.04.18

Gemini version available ♊︎

The Attacks on PTAB’s Legitimacy Are Slowing Down and § 101 Continues to be Applied by PTAB

Posted in America, Patents at 4:09 pm by Dr. Roy Schestowitz

Software patents are being invalidated and even examiners (with feedback from PTAB) increasingly reject these before grant

A reject bin

Summary: The Patent Trial and Appeal Board (PTAB) maintains its good work which reforms the Office and elevates the patent bar (narrowing scope); the USPTO is expected to see a decrease in patents this year, not just a decrease in the number of patent lawsuits

THE USPTO‘s PTAB needs no introduction here. We already wrote hundreds of articles about it and we commended its work, which helps raise the bar for patent examiners and thus improves patent quality in the US, disqualifies frivolous patent lawsuits before they go too far (because of profound financial damage to innocent parties that are merely being accused or threatened), gives businesses some peace of mind, and gives law firms something better to aim for (other than getting a gazillion patents on everything under the Sun).

PTAB is loved. It’s loved by those who actually create something.

PTAB is only (as far as we can see) hated by people who create nothing but lawsuits.

This post will focus on the latter group (the ‘haters’) because we feel the need to correct/rebut them.

Last week there was a decision in Knowles and it was discussed as follows: “Knowles Elecs v Cirrus Logic, FedCir 3/1/18; 2-1 majority affirms PTAB rejections in reexam for anticipation and lack of WD for proposed cls. Panel splits over impact of Circuit’s 2011 MEMS decision construing same term in same patent in ITC proceeding. Newman dissents on this.”

Newman dissents on a lot of stuff (we don’t want to bash her over it) and Dennis Crouch uses her dissent for his typical PTAB bashing because he’s not happy with the outcome (the PDF of this precedential decision was mentioned here). This is what Crouch wrote about PTAB:

The problem, for Judge Newman, is that a decision from the PTAB’s controlling court should control the actions of the PTAB and limit its power. For its part, the PTAB generally refuses to be bound by prior claim construction decisions by District Courts, but this is the first case where the PTAB has disregarded a prior interpretation by the Federal Circuit.

Although I began with Judge Newman’s opinion. Her opinion was in dissent, the Majority (Judges Wallach and Chen) avoided the question of whether the PTAB’s must follow Federal Circuit claim construction decisions. Rather, the majority held that the PTAB construction is in “accord with the definitions adopted in Mems Tech.” Based upon this claim construction, the majority agreed that the claims were anticipated by the proffered prior art.

Why did he begin with Newman’s opinion? That sort of bias is revealing, is it not?

Maybe the patent microcosm can just pretend to itself that only one judge exists and counts. The judge whom they like. The one they always/usually agree with. But that’s not how this court works. Notice the rather misleading/unhelpful title as well: “PTAB Reconstruing Claims: Estoppel?”

Poor outline of the case at hand, no? Maybe if Newman had Mexican heritage, Crouch would use another inane cartoon (or meme) of hers.

Moving on a bit, PTAB was also mentioned by Gaston Kroub of Kroub, Silbersher & Kolmykov PLLC. It’s not a coincidence that many proponents of software patents are also proponents of patent trolls, FRAND, SEP, the UPC etc. They are also opponents of patent quality control (something like PTAB). That’s just what patent maximalists are like. “It is well-known that patents are more valuable in certain industries than others,” Kroub said. “Whether it is because the eligibility of certain technology for patenting is in constant question — software, meet Alice — or because of the presence of standard-essential patents with their resultant FRAND obligations, in certain industries any given patent may not be very valuable. In contrast, industries like pharmaceuticals and medical devices, where a small set of patents can cover a blockbuster drug or device, are often thought of as having valuable patents. But recent developments have helped call this orthodoxy into question, particularly with respect to drug patents.”

Scroll down a bit for the anti-PTAB screed, for example: “Merck was not the only pharmaceutical giant to face an adverse decision recently. In another long-anticipated ruling, the PTAB found that Allergan’s attempt to end run the IPR process by assigning patents covering its blockbuster eye treatment Restasis to an Indian tribe would not result in the termination of the nearly-final IPRs. While the specifics of the decision are interesting, and raise important questions about the PTAB’s authority to decide issues other than patent validity, there is no doubt that the result is a blow to Allergan’s attempts to shield its Restasis patents from an ultimate invalidity finding — especially since the district court presiding over the corresponding ANDA case involving those patents had already found them invalid. Whether the generic challenger is heartened enough by this latest ruling to launch at-risk (pending Allergan’s inevitable Federal Circuit appeals) is an open question. What is clear, however, is that drug companies like Allergan are willing to try everything to keep their valuable patents alive. Despite those efforts, even the most creative (desperate?) strategies will not go far when the quality of the underlying patents are not commensurate with their purported value.”

We wrote about that case earlier today. PTAB receives plenty of hate for simply doing the right thing.

Doing the right thing seems to require courage these days because a whole bunch of patent law firms then resort to paid-for ‘articles’, racist memes, attacks on judges, endless efforts to cause scandals, and sometimes abusive letters. We’ve documented these over the years.

Crouch, a PTAB-hostile writer, is among those who are stressed to see patent sanity prevailing these days. See this new post which is at least suitably titled “Electronic Medical Records: Not Eligible” (obviously).

It’s about PTAB and an examiner:

IMO’s CEO Frank Naeymi-Rad along with 11 others are listed as inventors of the company’s pending Application No. 13/622,934 – recently rejected on eligibility grounds. The claims are directed to a software system for “implementing a controlled vocabulary” within a longitudinal medical record. The examiner finally rejected all 14 claims for on eligibility grounds (withdrawing the obviousness rejection) — concluding that the claims are directed to the abstract idea of “providing healthcare by generating and processing medical records.”

On appeal, the PTAB sided with the examiner – holding that – at a high level of abstraction, the claims “can be characterized as collecting, storing, and organizing … and transmitting information.” Although the examiner acknowledges that the claims are novel and non-obvious, the PTAB still found no inventive concept.

As we shall show later, examiners now growingly reject software patents and PTAB almost always affirms their decision (to reject). It’s an encouraging new trend. It’s not entirely new, but it’s gaining momentum.

It’s worth noting that attacks on PTAB are running dry. We track these things pretty carefully and closely. All in all, the anti-PTAB lobbying sites have slowed down lately. These anti-PTAB tweets, personal attacks, blog posts and articles may have halved in number (compared to months ago). Watchtroll, which used to attack PTAB almost every day (sometimes more than once a day), has lots of totally off-topic stuff. Watchtroll was bashing PTAB using the recent Arendi case (that was two days ago), but those sorts of articles come out about twice a week now, not twice a day like they used to.

Anticipat, which was trying to sell products/services by badmouthing PTAB, is also changing its tone somewhat. It’s softening.

Christopher Francis, writing for a law firm that loves bashing PTAB, is not happy about IPRs improving patent quality, but he too takes note of examiners’ change of habit:

The Patent Trial & Appeal Board applied In Re: Smith Int’l to limit the broadest reasonable interpretation of claim language in Ex parte David Ben Yair (Appeal 2017-002190, decided Jan. 10, 2018). In this case, the claim is directed toward a composite suit including “an inner suit” and “an outer suit,” and the prior art discloses a single article of clothing including an outer layer and an inner layer. The PTAB agreed with the appellant that, based on the specification of the appealed application, the claims required two pieces of clothing. Based on this interpretation the PTAB reversed the prior art rejection.

[...]

This type of analysis by the PTAB begs the question of whether examiners are now required to identify support in the specification for their interpretation of claim terms. In any case, this decision is an example of a broad application of In re: Smith Int’l that could be useful when working with the examiners on BRI issues and when appealing based on an Examiner’s broad claim interpretation.

PTAB haters are still out there, ranting in ALL CAPS because PTAB cites § 101, but those are a lot more extreme than any of the above. They are connected to literal patent trolls. They are so ‘fringe’ that they even deny that professors are professors (when they do not agree with them). The trolls they are connected to deny that I have a Ph.D. and yet it’s them who most habitually accuse PTAB of not caring about facts. The sheer hypocrisy.

Share in other sites/networks: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Reddit
  • email

Decor ᶃ Gemini Space

Below is a Web proxy. We recommend getting a Gemini client/browser.

Black/white/grey bullet button This post is also available in Gemini over at this address (requires a Gemini client/browser to open).

Decor ✐ Cross-references

Black/white/grey bullet button Pages that cross-reference this one, if any exist, are listed below or will be listed below over time.

Decor ▢ Respond and Discuss

Black/white/grey bullet button If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

DecorWhat Else is New


  1. IRC Proceedings: Wednesday, January 19, 2022

    IRC logs for Wednesday, January 19, 2022



  2. Links 20/1/2022: Linuxfx 11.1 WxDesktop 11.0.3 and FreeIPMI 1.6.9 Released

    Links for the day



  3. Links 19/1/2022: XWayland 22.1 RC1 and OnlyOffice 7.0 Release

    Links for the day



  4. Links 19/1/2022: ArchLabs 2022.01.18 and KDE's 15-Minute Bug Initiative

    Links for the day



  5. When Twitter Protects Abusers and Abuse (and Twitter's Sponsors)

    Twitter is an out-of-control censorship machine and it should be treated accordingly even by those who merely "read" or "follow" Twitter accounts; Twitter is a filter, not a news/media platform or even means of communication



  6. IRC Proceedings: Tuesday, January 18, 2022

    IRC logs for Tuesday, January 18, 2022



  7. Links 19/1/2022: Wine 7.x Era Begins and Istio 1.12.2 is Out

    Links for the day



  8. Another Video IBM Does Not Want You to Watch

    It seems very much possible that IBM (or someone close to IBM) is trying to purge me from Twitter, so let’s examine what they may be trying to distract from. As we put it 2 years ago, "Watson" is a lot more offensive than those supposedly offensive words IBM is working to purge; think about those hundreds of Red Hat workers who are black and were never told about ethnic purges of blacks facilitated by IBM (their new boss).



  9. What IBM Does Not Want You to Watch

    Let's 'Streisand it'...



  10. Good News, Bad News (and Back to Normal)

    When many services are reliant on the integrity of a single, very tiny MicroSD card you're only moments away from 2 days of intensive labour (recovery, investigation, migration, and further coding); we've learned our lessons and took advantage of this incident to upgrade the operating system, double the storage space, even improve the code slightly (for compatibility with newer systems)



  11. Someone Is Very Desperate to Knock My Account Off Twitter

    Many reports against me — some successful — are putting my free speech (and factual statements) at risk



  12. Links 18/1/2022: Deepin 20.4 and Qubes OS 4.1.0 RC4

    Links for the day



  13. Links 18/1/2022: GNOME 42 Alpha and KStars 3.5.7

    Links for the day



  14. IRC Proceedings: Monday, January 17, 2022

    IRC logs for Monday, January 17, 2022



  15. Links 17/1/2022: More Microsoft-Connected FUD Against Linux as Its Share Continues to Fall

    Links for the day



  16. The GUI Challenge

    The latest article from Andy concerns the Command Line Challenge



  17. Links 17/1/2022: digiKam 7.5.0 and GhostBSD 22.01.12 Released

    Links for the day



  18. IRC Proceedings: Sunday, January 16, 2022

    IRC logs for Sunday, January 16, 2022



  19. Links 17/1/2022: postmarketOS 21.12 Service Pack 1 and Mumble 1.4 Released

    Links for the day



  20. [Meme] Gemini Space (or Geminispace): From 441 Working Capsules to 1,600 Working Capsules in Just 12 Months

    Gemini space now boasts 1,600 working capsules, a massive growth compared to last January, as we noted the other day (1,600 is now official)



  21. [Meme] European Patent Office Space

    The EPO maintains a culture of illegal surveillance, inherited from Benoît Battistelli and taken to a whole new level by António Campinos



  22. Gemini Rings (Like Webrings) and Shared Spaces in Geminspace

    Much like the Web of 20+ years ago, Gemini lets online communities — real communities (not abused tenants, groomed to be ‘monetised’ like in Facebook or Flickr) — form networks, guilds, and rings



  23. Links 16/1/2022: Latte Dock 0.11 and librest 0.9.0

    Links for the day



  24. The Corporate Cabal (and Spy Agencies-Enabled Monopolies) Engages in Raiding of the Free Software Community and Hacker Culture

    In an overt attack on the people who actually did all the work — the geeks who built excellent software to be gradually privatised through the Linux Foundation (a sort of price-fixing and openwashing cartel for shared interests of proprietary software firms) — is receiving more widespread condemnation; even the OSI has been bribed to become a part-time Microsoft outsourcer as organisations are easier to corrupt than communities



  25. EPO's Web Site Constantly Spammed by Lies About Privacy While EPO Breaks the Law and Outsources Data to the United States

    The António Campinos-led EPO works for imperialism, it not only protects the rich; sadly, António’s father isn’t alive anymore and surely he would blast his son for doing what he does to progress his career while lying to staff and European citizens



  26. Links 16/1/2022: Tsunami and Patents

    Links for the day



  27. IRC Proceedings: Saturday, January 15, 2022

    IRC logs for Saturday, January 15, 2022



  28. Links 16/1/2022: Year of the GNU/Linux Desktop and Catch-up With Patent Misinformation

    Links for the day



  29. Patrick Breyer, Unlike Most German Politicians, Highlights the Fact That Unified Patent Court (UPC) and Unitary Patent Are Incompatible With EU Law

    A longtime critic of EPO abuses (under both Benoît Battistelli and António Campinos leadership), as well as a vocal critic of software patents, steps in to point out the very obvious



  30. Links 15/1/2022: Flameshot 11.0 and Libvirt 8.0

    Links for the day


RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

Recent Posts